Radient Pays $2.5M To End Claims It Lied About Mayo Clinic
Radient Pharmaceuticals Corp. has agreed to pay $2.5 million to settle a class action brought by investors who allege the company falsely claimed to have a clinical testing partnership with the...To view the full article, register now.
Already a subscriber? Click here to view full article